User Name:


remember me

Forgot your password?

Not a member?

Join Now

News Topic - FDA

RSS feedDisplaying articles 1 - 10 of most recent articles

Device in drug program gets FDA approval A device meant to help relieve the symptoms of withdrawal from opioid addiction has gotten clearance from the U.S. Food and Drug Administration. The BRIDGE device is being used by a Greenwood city court program geared toward people addicted to opioids. Th
Daily Journal of Johnson County | Nov 18, 2017 07:11 AM [GMT] | comment? | recommend article from Franklin, Indiana
Photo from WFIE - 14
FDA approves new opioid-withdrawal device, offered at Evansville's Boyett Treatment Center A new device is giving opioid addicts another option to get clean.It's called the Neuro-Stim System Bridge, and it's available right here in Evansville.
WFIE - 14 | Nov 18, 2017 12:10 AM [GMT] | comment? | recommend article from Evansville, Indiana
Photo from Mail Online
Duchenne muscular dystrophy sufferers cannot walk Brothers Elliot Johnson, 14, and Henry, 11, from Pennsylvania fear they won't be able to walk again after the FDA pulled the drugs that have kept their rare muscle disorder under control.
Mail Online | Nov 17, 2017 11:07 PM [GMT] | comment? | recommend
Beautycounter--the Leader in Safer Beauty--Endorses Personal Care Products Safety Act Joined by a group of safer beauty brands, the company backs bill introduced by Senators Feinstein and Collins calling for FDA authority to regulate safety of beauty products WASHINGTON, Nov. 17, 2017 /PRNewswire/ -- Counter Brands, LLC. parent company of
PR Newswire | Nov 17, 2017 9:35 PM [GMT] | comment? | recommend
The FDA closes a huge loophole used by bogus stem cell clinics, but postpones serious enforcement There was good news and bad news in the regulatory initiative the Food and Drug Administration rolled out on Thursday, aimed partially at clinics marketing unproven stem-cell therapies directly to consumers. The good news is that the FDA firmly closed a l
Los Angeles Times | Nov 17, 2017 9:30 PM [GMT] | comment? | recommend
Insulia erhlt die FDA-Zulassung und CE-Kennzeichnung fr die Integration von Basaglar und Tresiba Insulia ist damit fr die Titration aller Marken von Basalinsulin zugelassen CAMBRIDGE, Massachusetts, 17. November 2017 /PRNewswire/ -- Voluntis gab heute bekannt, dass Insulia, sein digitaler Begleiter fr Menschen mit Typ-2-Diabetes, die FDA-Zulassung un
PR Newswire | Nov 17, 2017 1:48 PM [GMT] | comment? | recommend
Insulia a reu l'agrment de la FDA et le marquage CE en vue d'intgrer le Basaglar et le Tresiba Insulia dtient dsormais un agrment pour le titrage de toutes les marques d'insuline basale CAMBRIDGE, Massachusetts, le 17novembre2017 /PRNewswire/ --Aujourdhui, Voluntis a annonc qu'Insulia, son logiciel compagnon pour les personnes sou
PR Newswire | Nov 17, 2017 1:39 PM [GMT] | comment? | recommend
MiMedx Market Leadership Well Positioned In Light Of FDA New Guidance Document MARIETTA, Ga., Nov. 17, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processe
PR Newswire | Nov 17, 2017 1:06 PM [GMT] | comment? | recommend
FDA clears Indiana-made Bridge Device to help detox from opioids Read full story for latest details. | Nov 17, 2017 12:03 AM [GMT] | comment? | recommend article from Indianapolis, Indiana
FDA says it will crack down on risky stem cell offerings U.S. health authorities announced plans Thursday to crack down on doctors pushing stem cell procedures that pose the gravest risks to patients amid an effort to police a burgeoning medical field that previously has received little oversight. The Food and
South Florida Sun-Sentinel | Nov 16, 2017 10:30 PM [GMT] | comment? | recommend article from Fort Lauderdale, Florida